BHF clinical training research fellow, utilising advanced cardiac imaging in cancer survivorship. HER-SAFE study: https://xitter.cf/t.co/9U279EhMjX

UCL
Joined October 2012
How long do I have to stay on meds after CTRCD? In HER SAFE carefully selected population it was safe to stop. Huge Congratulations @dr_manisty and her mentees on this important practice-informingbstudy!#ESCCongress @ehj_ed
Heart function stayed stable at 1 year after carefully monitored withdrawal of heart failure therapy in breast cancer survivors with recovered anti-HER2 cardiotoxicity. Work from our group at @ucl, presented by @bmdwsg as a Late-Breaking Trial at #ESCCongress 2026 & published simultaneously in @ehj_ed: HER-SAFE. @TheBHF @escardio @MycardiumAI #CardioOnc 🔗 academic.oup.com/eurheartj/a…
6
24
1,255
🚨 Two randomized #CardioOncology trials at #ESCCongress2026! 🫀 RADICAL PC2: CV referral improved risk-factor control in prostate cancer. 💗 HER-SAFE: HF therapy withdrawal after recovery from anti-HER2 CTRCD appeared safe at 12 months. @escardio @ESC_Journals
19
2
30
2,648
Heart function stayed stable at 1 year after carefully monitored withdrawal of heart failure therapy in breast cancer survivors with recovered anti-HER2 cardiotoxicity. Work from our group at @ucl, presented by @bmdwsg as a Late-Breaking Trial at #ESCCongress 2026 & published simultaneously in @ehj_ed: HER-SAFE. @TheBHF @escardio @MycardiumAI #CardioOnc 🔗 academic.oup.com/eurheartj/a…
3
15
1
50
3,268
Today Dr Ben Dowsing @bmdwsg presented the #HERSAFE trial. Can we safely stop CV medication after cancer treatment? All the answers in this #EHJ publication! academic.oup.com/eurheartj/a… @sohaibnazir @dr_manisty @arjunkg @ehj_ed
2
14
619
Excited to see our work on myocardial fibrosis and reverse remodelling after AVR for chronic aortic regurgitation published in @JAMACardio! lnkd.in/eCcS-BjD At 7 months post AVR: 🔹 LVEDV ↓44% 🔹 LV mass ↓21% 🔹 Matrix ↓15% But focal scar did not regress #whyCMR @TheBHF
1
10
3
28
6,024
Glad to see our paper published in the European Heart Journal: Cardiovascular Imaging @ESC_Journals! In 5,675 Cardiac MRI studies, asymmetrical septal hypertrophy (ASH) was present in 61% of hypertrophic cardiomyopathy (HCM) patients, but also 37% of ATTR amyloidosis, 26% of aortic stenosis and 23% of AL amyloidosis. After accounting for age, sex & body size, however, excess asymmetry remained uniquely associated with HCM (ΔSLR +0.27). doi.org/10.1093/ehjci/jeag20…
2
6
11
748
#PublicationAlert 🚨 A study led by @mrcunitgambia in partnership with @radboudumc and @ChariteBerlin, shows that vaccinating #PregnantWomen against #WhoopingCough protects babies in their blood and nasal lining, where infection starts. Read more 👉 tinyurl.com/3e85e85z
1
2
6
939
📞 Calling all Imaging Experts - we need your help. Please fill out this survey to help us understand your successes and challenges in cardiac imaging for cancer patients. Link: redcap.slms.ucl.ac.uk/survey… #cardioonc #cardiacimaging #cardiooncology #cardiology #oncology #cancertreatment
2
1
180
Fantastic summary. Clinicians often underestimate the impact of lifelong poly pharmacy - “you say treatment, I say hard work!”. HER-SAFE will address GDMT withdrawal in breast cancer survivors with HFimpEF following antiHER cardiac dysfunction. Recruitment finishing soon!
In #JACCHF, Drs. Nandan Kodur & @WilsonTangMD review management of #HFimpEF 🔸Who must continue #GDMT? 🔸What are characteristics of those who may be able to withdraw? 🔸Where are the evidence gaps? 🔸What are areas for future study 🔗: jacc.org/doi/10.1016/j.jchf.…
1
2
439
In #JACCHF, Drs. Nandan Kodur & @WilsonTangMD review management of #HFimpEF 🔸Who must continue #GDMT? 🔸What are characteristics of those who may be able to withdraw? 🔸Where are the evidence gaps? 🔸What are areas for future study 🔗: jacc.org/doi/10.1016/j.jchf.…
6
1
28
4,022
🚨Publication alert🚨 Can HF drugs be stopped after #cancer treatment and cardiac recovery? This RCT will provide some answers! 👏Congratulations to @bmdwsg & @dr_manisty for leading this work! 🙏Grateful to be part of the team. 📖full study protocol : doi.org/10.1136/bmjopen-2024…
2
7
2
23
1,728
A huge thanks to @MariaSolAndres1 and everyone working so hard to make HER-SAFE a success! Looking forward to providing some high quality evidence in this uncertain area of breast cancer survivorship. @TheBHF @UCL_ICS @NHSBartsHealth @uclh @RBandH @ImperialNHS
🚨Publication alert🚨 Can HF drugs be stopped after #cancer treatment and cardiac recovery? This RCT will provide some answers! 👏Congratulations to @bmdwsg & @dr_manisty for leading this work! 🙏Grateful to be part of the team. 📖full study protocol : doi.org/10.1136/bmjopen-2024…
1
8
514
DAPA-HF at #esccongress: use of SGLT2 inhibitor Dapagliflozin in addition to standard care in pts with EF<40% resulted in: ♥️ 26% ⬇️ death/worsening HF ♥️ 18%⬇️ CV death ♥️ 30%⬇️ worsening HF In both pts with AND without diabetes #CardioEd #heartfailure
4
69
9
137
#ESCCongress morning thoughts - cardiovascular mortality is higher than cancer mortality in breast cancer patients - Prof Suter @escardio
3
65
7
130